Relaxin and renal fibrosis

Kidney International

Volumn 59, Issue 3, 2001, Pages 1184-1185

  Becker, G J ^a   Hewitson, T D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RELAXIN;

EDITORIAL; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HYPERLIPIDEMIA; KIDNEY FIBROSIS; PRIORITY JOURNAL; PROTEIN INTAKE;

EID: 0035095220     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590031184.x     Document Type: Editorial

References (10)

1. The role of tubulointerstitial injury in chronic renal failure
2. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease
3. Relaxin: A pleiotropic hormone
4. Relaxin induces an extracellular matrix degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo
5. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis
6. Recombinant human relaxin in the treatment of scleroderma: A randomized, double-blind, placebo-controlled trial
7. Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis
8. Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts
9. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts
10. Relaxin is a potent renal vasodilator in conscious rats